pentoxifylline has been researched along with Pulmonary Hypertension in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inhalation of aerosolized iloprost, a stable prostacyclin analog, has been suggested for treatment of primary and secondary pulmonary hypertension, but demands multiple daily inhalation maneuvers because of the short-term effect of this approach." | 7.71 | Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity. ( Ghofrani, HA; Grimminger, F; Krupnik, E; Rose, F; Schermuly, RT; Schudt, C; Seeger, W; Tenor, H; Walmrath, D; Weissmann, N, 2001) |
| "Inhalation of aerosolized iloprost, a stable prostacyclin analog, has been suggested for treatment of primary and secondary pulmonary hypertension, but demands multiple daily inhalation maneuvers because of the short-term effect of this approach." | 3.71 | Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity. ( Ghofrani, HA; Grimminger, F; Krupnik, E; Rose, F; Schermuly, RT; Schudt, C; Seeger, W; Tenor, H; Walmrath, D; Weissmann, N, 2001) |
| " Thromboxane A2 is the major mediator of the early pulmonary hypertension associated with endotoxemia, but the mechanisms underlying the prolonged hemodynamic disturbances observed in ongoing endotoxemia are not well understood." | 3.69 | Delayed thromboxane or tumor necrosis factor-alpha, but not leukotriene inhibition, attenuates prolonged pulmonary hypertension in endotoxemia. ( Li, JX; Lu, CY; Oliver, JR; Philips, JB, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, MK | 1 |
| Babaali, H | 1 |
| Gilbert-McClain, LI | 1 |
| Stylianou, M | 1 |
| Joo, J | 1 |
| Moss, J | 1 |
| Manganiello, VC | 1 |
| Li, JX | 1 |
| Oliver, JR | 1 |
| Lu, CY | 1 |
| Philips, JB | 1 |
| Lauterbach, R | 1 |
| Manohar, M | 2 |
| Goetz, TE | 2 |
| Rothenbaum, P | 2 |
| Humphrey, S | 2 |
| Schermuly, RT | 2 |
| Roehl, A | 1 |
| Weissmann, N | 2 |
| Ghofrani, HA | 2 |
| Leuchte, H | 1 |
| Grimminger, F | 2 |
| Seeger, W | 2 |
| Walmrath, D | 2 |
| Krupnik, E | 1 |
| Tenor, H | 1 |
| Schudt, C | 1 |
| Rose, F | 1 |
| Truog, WE | 1 |
| Gibson, RL | 1 |
| Henderson, WR | 1 |
| Redding, GJ | 1 |
| Standaert, TA | 1 |
1 trial available for pentoxifylline and Pulmonary Hypertension
| Article | Year |
|---|---|
Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis.
Topics: Adolescent; Adult; Aged; Biopsy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forc | 2009 |
7 other studies available for pentoxifylline and Pulmonary Hypertension
| Article | Year |
|---|---|
Delayed thromboxane or tumor necrosis factor-alpha, but not leukotriene inhibition, attenuates prolonged pulmonary hypertension in endotoxemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Endotoxins; Female; Hemodynamics; Humans; Hypertension, Pulmo | 1995 |
Pentoxifylline treatment of persistent pulmonary hypertension of newborn.
Topics: Chronic Disease; Humans; Hypertension, Pulmonary; Infant, Newborn; Infant, Premature, Diseases; Pent | 1993 |
Intravenous pentoxifylline does not affect the exercise-induced pulmonary arterial, capillary or venous hypertension in Thoroughbred horses.
Topics: Animals; Breeding; Female; Hemodynamics; Horse Diseases; Horses; Hypertension, Pulmonary; Injections | 2000 |
Intravenous pentoxifylline does not enhance the pulmonary haemodynamic efficacy of frusemide in strenuously exercising thoroughbred horses.
Topics: Animals; Breeding; Diuretics; Drug Administration Schedule; Drug Interactions; Female; Furosemide; H | 2001 |
Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Anim | 2001 |
Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aerosols; Animals; Dipyridamole; | 2001 |
Effect of pentoxifylline on cytokine- and eicosanoid-induced acute pulmonary hypertension in piglets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Disease; Animals; Animals, | 1992 |